Research & Reports
Sep 20, 2026•1 min read
Anguk Pharmaceutical Partners with Selbion to Develop Next-Gen Radiopharmaceutical Cancer Therapies
Anguk Pharmaceutical and radiopharmaceutical specialist Selbion have signed an MOU to collaborate on innovative radiopharmaceutical therapies and discover new oncology drug pipelines.
1
Research & Reports
Sep 14, 2026•1 min read
Ewha Aortic Vascular Hospital and FlowNix Sign MOU to Co‑Develop Integrated Aortic Care Solution
Ewha Aortic Vascular Hospital and imaging firm FlowNix have agreed to jointly develop an integrated solution covering the full clinical workflow for aortic patients, from diagnosis to long‑term follow‑up.
Research & Reports
Sep 12, 2026•1 min read
GeoYoung partners with A.D Cure to launch Voice AI solution H2V
GeoYoung, Korea’s largest healthcare platform, has signed an MOU with voice AI digital health firm A.D Cure to discuss sales, distribution and commercialization of the ‘Heart to Voice (H2V)’ solution and other collaborative opportunities.
Research & Reports
Sep 2, 2026•1 min read
Insilico Medicine and China Medical System Holdings Sign $1.77B CNS Co‑Development Deal
Insilico Medicine and China Medical System Holdings have agreed to a 12 billion‑yuan (≈$1.77 billion) partnership to co‑develop central nervous system therapies using Insilico’s PandaOmics AI platform.
Research & Reports
Aug 30, 2026•1 min read
SK Biopharm Partners with Insilico Medicine on AI-Driven CNS Drug Discovery
SK Biopharm has signed a joint R&D agreement with AI-driven Insilico Medicine to develop CNS therapeutics, focusing on neuroimmune targets, announced at the 2026 Bio International Convention.